News & Updates

Aquablation therapy appears to be effective in benign prostatic hyperplasia (BPH) patients experiencing lower urinary tract symptoms, with the favourable effects sustained over a 3-year follow-up while having few irreversible complications and low retreatment rates across all prostate volumes, according to a study.

Compared with infections, noninfectious complications are more than twice as common following transrectal prostate needle biopsy (TRUS PNB), reports a recent study.

Treatment with the combination of tamsulosin plus mirabegron following 125I-brachytherapy for prostate cancer falls short of improving voiding volume compared with tamsulosin monotherapy, although the combination helps with urination frequency and overactive bladder symptoms, according to a study.

Use of a motion-based digital device to guide pelvic floor muscle training effectively mitigates symptoms of urinary incontinence (UI) as well as reduces UI episodes relative to a home training program that consists of written and narrated instructions, as shown in a study.

The growth rates of transition and peripheral zones of the prostate vary, according to a study. Body mass index (BMI) and transition zone index (TZI) contribute to peripheral zone growth rate, while use of 5-alpha reductase inhibitor (5ARI) reduces the transition zone growth rate.